智能应用程序辅助的超慢跑与固定自行车对大学生呼吸功能和有氧适能影响的比较
比较智能应用辅助的超慢跑与固定自行车对大学生呼吸功能与有氧适能的影响
As health awareness continues to rise, more people are prioritizing exercise to improve physical condition and enhance overall fitness. For those lacking exercise habits, selecting a simple, accessible, and effective workout becomes crucial. Against a backdrop of prolonged sitting and inactivity, "super slow jogging" is gaining attention. This aerobic exercise involves a slow walking pace and low intensity, yet burns more calories than regular walking, making it an ideal entry-level activity for beginners or those with lower fitness levels. This study aims to investigate whether incorporating super slow jogging training can effectively enhance cardiorespiratory fitness and respiratory function, comparing its outcomes with other exercise types. The purpose of this experiment is academic research, primarily exploring the impact of exercise intervention on physiological functions. It is not intended for health screening or medical diagnosis.
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Daliao
-
Kaohsiung City、Daliao、台湾、831301
- No. 151, Jinxue Rd.
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- required no regular exercise training in the past six months
- ability to safely perform high-intensity cycling exercise
Exclusion Criteria:
- musculoskeletal limitations that prevented cycling exercise
- recent infection
- known cardiopulmonary disease or medical history affecting cardiovascular or respiratory function
- smoking
- use of medications that may influence cardiopulmonary responses to exercise
- other contraindications to exercise testing according to the American College of Sports Medicine (ACSM) guidelines
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Super slow jogging
A smart app will provide pacing assistance, adjusting step frequency weekly: Week 1: 150 steps per minute Week 2: 180 steps per minute Week 3: 190 steps per minute Week 4: 200 steps per minute |
This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down. Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly: Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max). Control Group: No exercise training intervention. |
|
实验性的:moderate exercise training
Continuous cycling training at moderate intensity of 60% VO₂max |
This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down. Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly: Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max). Control Group: No exercise training intervention. |
|
安慰剂比较:Control
not perform any exercise training |
This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down. Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly: Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max). Control Group: No exercise training intervention. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Cardiopulmonary Fitness
大体时间:Before intervention and the end of intervention at 12 weeks
|
VO2max (ml/kg/mL) |
Before intervention and the end of intervention at 12 weeks
|
|
Baseline anthropometric of the participants
大体时间:Before intervention and the end of intervention at 12 weeks
|
Age (yr) |
Before intervention and the end of intervention at 12 weeks
|
|
Cardiopulmonary Fitness
大体时间:Before intervention and the end of intervention at 12 weeks
|
VEmax (L/min) |
Before intervention and the end of intervention at 12 weeks
|
|
Cardiopulmonary Fitness
大体时间:Before intervention and the end of intervention at 12 weeks
|
AT% (%VO₂max) |
Before intervention and the end of intervention at 12 weeks
|
|
Cardiopulmonary Fitness
大体时间:Before intervention and the end of intervention at 12 weeks
|
Resting O₂ pulse (mL·beat-¹) |
Before intervention and the end of intervention at 12 weeks
|
|
Cardiopulmonary Fitness
大体时间:Before intervention and the end of intervention at 12 weeks
|
Max O₂ pulse (mL·beat-¹) |
Before intervention and the end of intervention at 12 weeks
|
|
Cardiopulmonary Fitness
大体时间:Before intervention and the end of intervention at 12 weeks
|
MIP (cmH2O) |
Before intervention and the end of intervention at 12 weeks
|
|
Cardiopulmonary Fitness
大体时间:Before intervention and the end of intervention at 12 weeks
|
MEP (cmH2O) |
Before intervention and the end of intervention at 12 weeks
|
|
Baseline anthropometric of the participants
大体时间:Before intervention and the end of intervention at 12 weeks
|
Height (cm) |
Before intervention and the end of intervention at 12 weeks
|
|
Baseline anthropometric of the participants
大体时间:Before intervention and the end of intervention at 12 weeks
|
Weight (kg) |
Before intervention and the end of intervention at 12 weeks
|
|
Baseline anthropometric of the participants
大体时间:Before intervention and the end of intervention at 12 weeks
|
BMI (kg/m²) |
Before intervention and the end of intervention at 12 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Lung function
大体时间:Before intervention and the end of intervention at 12 weeks
|
FEV1 (L) |
Before intervention and the end of intervention at 12 weeks
|
|
Lung function
大体时间:Before intervention and the end of intervention at 12 weeks
|
FVC (L) |
Before intervention and the end of intervention at 12 weeks
|
|
Lung function
大体时间:Before intervention and the end of intervention at 12 weeks
|
FEV₁/FVC (%) |
Before intervention and the end of intervention at 12 weeks
|
|
Lung function
大体时间:Before intervention and the end of intervention at 12 weeks
|
FEF25-75% (L·s-¹) |
Before intervention and the end of intervention at 12 weeks
|
|
Lung function
大体时间:Before intervention and the end of intervention at 12 weeks
|
PEF (L·min-¹) |
Before intervention and the end of intervention at 12 weeks
|
|
Lung function
大体时间:Before intervention and the end of intervention at 12 weeks
|
MVV (L·min-¹) |
Before intervention and the end of intervention at 12 weeks
|
|
Lung function
大体时间:Before intervention and the end of intervention at 12 weeks
|
Breathing reserve (%) |
Before intervention and the end of intervention at 12 weeks
|
|
Lung function
大体时间:Before intervention and the end of intervention at 12 weeks
|
Dynamic Index (DI%) |
Before intervention and the end of intervention at 12 weeks
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 114-0561
- 114-2813-C-242-003-B (其他赠款/资助编号:National Science and Technology Council, Taiwan)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.